 |
|
Lithium Carbonate in Affective DisordersIV. A Double-Blind Study of Prophylaxis in Unipolar Recurrent Depression
Ronald R. Fieve, MD;
David L. Dunner, MD;
Turkan Kumbarachi, PhD;
Frank Stallone, PhD
Arch Gen Psychiatry. 1975;32(12):1541-1544.
Abstract
• The prophylactic efficacy of lithium carbonate vs placebo was examined in a double-blind study in a carefully delineated group of 28 unipolar recurrent depressed patients followed up from three months to four years. Indexes of prophylactic efficacy revealed a statistically significant decrease in episode frequency, depth of global depression scores, and increased clinic attendance rate in the lithium carbonate group compared with the placebo group.
Planned studies are now needed to determine which unipolar patients do best on a maintenance regimen of lithium carbonate alone, lithium carbonate plus tricyclic drugs, or tricyclic drugs alone.
Author Affiliations
From the Lithium Clinic and Metabolic Research Unit, New York State Psychiatric Institute, New York.
Footnotes
Accepted for publication Sept 17, 1975.
Reprint requests to Department of Internal Medicine, New York State Psychiatric Institute, 722 W 168th St, New York, NY 10032 (Dr Fieve).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Lithium in the Prophylactic Treatment of Affective Disorders
Prien
Arch Gen Psychiatry 1979;36:847-848.
ABSTRACT
Prophylaxis of Affective Disorders: Current Status of Knowledge
Quitkin et al.
Arch Gen Psychiatry 1976;33:337-341.
ABSTRACT
Lithium Carbonate and Affective Disorders: V: A Double-Blind Study of Prophylaxis of Depression in Bipolar Illness
Dunner et al.
Arch Gen Psychiatry 1976;33:117-120.
ABSTRACT
|
